BioPharma
19 January, 2026 | Monday | News
Navigating European Regulatory and Market Access Pathways: Crucial Considerations from TMC’s Catherine Moncad
As more APAC biotech and pharma companies look to Europe for regulatory approval and commercialisation, navigating complex EU and UK requirements early is becoming increasingly critical. BioPharma APAC spoke wi...
Lab
21 January, 2026 | Wednesday | News
From Capacity to Capability: How 2026 can be the catalyst for what APAC’s Biopharma Growth Needs Next
Beyond Scale: What Will Sustain APAC’s Biopharma Leadership Asia-Pacific’s rise in global biopharma is no longer about whether the region can compete. It already manufactures at scale, attracts int...
BioTech
05 January, 2026 | Monday | Expert Insight
How Asia Pacific Is Forcing A Rethink On Surgical Outcomes Measurement
As surgical volumes rise and care pathways grow more complex across Asia Pacific, the limitations of how post operative outcomes are measured are becoming increasingly clear. In this in depth interview for BioP...
Contract Services
19 January, 2026 | Monday | News
Dr Chris Chen Positions WuXi Biologics As The Defining Force Shaping The Future Of Global CRDMO Innovation
Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects in 2025 set a new record, with approximately 50% origin...
Consumer Health
05 January, 2026 | Monday | Opinion
Leading the Future of Care: Patient Organizations Driving Health System Transformation
Real Change Starts with Listening Across the Asia Pacific, Middle East, and Africa, healthcare systems are facing mounting pressures with rising rates of preventable chronic disease, gaps in early detection, a...
White Paper
05 January, 2026 | Monday | News
26 Key Trends Shaping Biotech And Life Sciences In 2026
Product Spot Light
15 January, 2026 | Thursday | News
Animate Biosciences Delivers Ai Designed Peptides That Match Standard Of Care In Pulmonary Fibrosis Model
Premium Article
15 December, 2025 | Tuesday | Report
APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
Bio Invest
Biopharma APAC Infomercial
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
